CLINICAL_TRIALS
trial_result
· 2021-05-26
Clinical Trial Update: Nigella Sativa in COVID-19 [Phase 2]
Summary
Phase 2 clinical trial update evaluating Nigella Sativa for COVID-19; trial completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: King Abdulaziz University | Conditions: COVID-19, SARS-CoV-2 | Phase 2 | Status: COMPLETED | Results posted: 2021-05-26